Advancing Liver Cancer Precision Medicine with TARGET-SL
Rhys Gillman, Benjamin J. Dwyer, Sara Pasic, Gayatri D. Shirolkar, Nathan Main, The Liver Cancer Collaborative, Matthew A. Field, Ulf Schmitz, Lionel Hebbard
This paper validates the TARGET-SL framework for predicting genetic events and drug sensitivities in liver cancer using cell lines and patient-derived organoids, showing potential to improve personalized drug screening.
bioRxiv · May 21, 2026 · PreprintCancer Biology